Innaxon, s.r.o seeks to grow through collaborations, partnerships and new ventures.

Where appropriate, we pursue key technology and product licensing/acquisition strategies to build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key of the innate immune system -Toll-like Receptor 4- to serve serious, unmet medical needs.